Abstract
The effects of eight serotonin (5-HT) receptor antagonists on the anorectic effect of d-fenfluramine (3.0 mg/kg, IP) were examined in a test of sweet mash consumption, using non-deprived male rats. d-Fenfluramine's effect was attenuated by the mixed 5-HT1/5-HT2 receptor antagonists, methiothepin and metergoline; by the 5-HT2 receptor antagonist ritanserin; and by (±)cyanopindolol, a mixed 5-HT1A/5-HT1B receptor antagonist. In contrast, d-fenfluramine's effect was not antagonised by the 5-HT2 receptor antagonists ketanserin and ICI 169 369; the 5-HT3 receptor antagonist ICS 205 930; or by xylamidine, a peripheral 5-HT receptor antagonist. In this feeding model, none of the 5-HT antagonists, when tested alone, had any effect to increase palatable food consumption. The pattern of results obtained strongly suggest that central 5-HT1 receptors play an important role in the mediation of d-fenfluramine-induced anorexia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baker BJ, Duggan JP, Barber DJ, Booth DA (1988) Effects of dl-fenfluramine and xylamidine on gastric emptying of maintenance diet in freely feeding rats. Eur J Pharmacol 150: 137–142
Barrett AM, McSharry L (1975) Inhibition of drug-induced anorexia in rats by methysergide. J Pharma Pharmacol 27: 889–895
Blackburn TP, Thornber CW, Pearce RJ, Cox B (1987) In vivo pharmacology of ICI 169 369 — a new 5-HT2 antagonist. Br J Pharmacol 90: 277P
Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23: 1537–1551
Blundell JE, Latham CJ (1980) Characterisation of adjustments to the structure of feeding behavior following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline. Pharmacol Biochem Behav 12: 717–722
Borsini F, Bendotti C, Aleotti A, Samanin R, Garattini S (1982) d-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. Pharmacol Res Commun 14: 671–678
Borsini F, Bendotti C, Samanin R (1985) Salbutamol, d-amphetamine and d-fenfluramine reduce sucrose intake in freely fed rats by acting on different neurochemical mechanisms. Int J Obes 9: 277–283
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576
Carruba MO, Mantegazza P, Memo M, Missale C, Spano PF (1986) Peripheral and central mechanisms of action of serotonergic anorectic drugs. Appetite [Suppl] 7: 105–113
Clineschmidt BV, McGuffin JC, Werner AB (1974) Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloroamphetamine. Eur J Pharmacol 27: 313–323
Cooper SJ (1986) Hyperphagic and anorectic effects of β-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam. Eur J Pharmacol 120: 257–265
Copp FC, Green AF, Hodson HF, Randall AW, Sim MF (1967) New peripheral antagonists of 5-hydroxytryptamine. Nature 214: 200–201
Dourish CT, Cooper SJ, Gilbert F, Coughlan J, Iversen SD (1988a) The 5-HT1A agonist 8-OH-DPAT increases consumption of palatable wet mash and liquid diets in the rat. Psychopharmacology 94: 58–63
Dourish CT, Clark ML, Fletcher A, Iversen SD (1988b) Evidence that blockade of postsynaptic 5-HT1 receptors elicits feeding in satiated rats. Psychopharmacology (in press)
Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332: 1–7
Fletcher PJ (1987) Serotonin antagonists and feeding. Soc Neurosci Abstr 13: 1173
Fletcher PJ, Burton MJ (1986) Dissociation of the anorectic actions of 5-HTP and fenfluramine. Psychopharmacology 89: 216–220
Fuller RW, Kurz KD, Mason NR, Cohen MC (1986) Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Eur J Pharmacol 125: 71–77
Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R (1986a) Neurochemical mechanism of action of drugs which modify feeding via the serotonergic system. Appetite [Suppl] 7: 15–38
Garattini S, Mennini T, Samanin R (1986b) From fenfluramine racemate to d-fenfluramine; specificity and potency of the effects on the serotoninergic system and food intake. Ann NY Acad Sci 499: 156–166
Heuring RE, Peroutka SJ (1987) Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7: 894–903
Hewson G, Leighton GE, Hill RG, Hughes J (1988) Ketanserin antagonises the anorectic effect of dl-fenfluramine in the rat. Eur J Pharmacol 145:227–230
Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res (in press)
Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]cyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118: 13–23
Invernizzi R, Berettera C, Garattini S, Samanin R (1986) d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 120: 9–15
Jespersen J, Scheel-Krüger J (1973) Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia. J Pharm Pharmacol 25: 49–54
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28: 1015–1022
Leysen JE, Gommeren W, Van Gompel P, Wynans J, Janssen PAJ, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27: 600–611
Massi M, Marini S (1987) Effect of the 5-HT2 antagonist ritanserin on food intake and on 5-HT-induced anorexia in the rat. Pharmacol Biochem Behav 26: 333–340
Mawson C, Whittington H (1970) Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol 39: 223P
Middlemiss DN, Hibert M, Fozard JR (1986) Drugs acting at central 5-hydroxytryptamine receptors. Annu Rep Med Chem 21: 41–50
Neill JC, Cooper SJ (1988) Evidence for serotonergic modulation of sucrose sham-feeding in the gastric-fistulated rat. Physiol Behav (in press)
Pazos A, Hoyer D, Palacios JM (1985) The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur J Pharmacol 106: 539–546
Pedigo NW, Yamamura HI, Nelson DC (1981) Discrimination of multiple 3H 5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36: 220–226
Pollock JD, Rowland N (1981) Peripherally administered serotonin decreases food intake in rats. Pharmacol Biochem Behav 15: 179–183
Simansky KJ, Cohen BI, Eberle K (1987) Inhibition by 5-HT2 antagonists of the anorexic actions of peripherally administered 5-hydroxytryptamine (5-HT) and 4-HT in rats. Soc Neurosci Abstr 13: 15
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126–131
Rowland NE, Carlton J (1986) Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27: 13–62
Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neill, J.C., Cooper, S.J. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 97, 213–218 (1989). https://doi.org/10.1007/BF00442252
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442252